Kissy Guevara‐Hoyer

702 total citations
28 papers, 212 citations indexed

About

Kissy Guevara‐Hoyer is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kissy Guevara‐Hoyer has authored 28 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Kissy Guevara‐Hoyer's work include Immunodeficiency and Autoimmune Disorders (12 papers), Cystic Fibrosis Research Advances (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Kissy Guevara‐Hoyer is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (12 papers), Cystic Fibrosis Research Advances (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Kissy Guevara‐Hoyer collaborates with scholars based in Spain, Portugal and Canada. Kissy Guevara‐Hoyer's co-authors include Silvia Sánchez‐Ramón, Jesús Fuentes‐Antrás, Miguel Fernández‐Arquero, Pedro Pérez‐Segura, Rebeca Pérez de Diego, Alberto Ocaña, Mariona Baliu‐Piqué, Atanasio Pandiella, José Á. García-Sáenz and Carmen M. Diez‐Rivero and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Scientific Reports.

In The Last Decade

Kissy Guevara‐Hoyer

25 papers receiving 207 citations

Peers

Countries citing papers authored by Kissy Guevara‐Hoyer

Since Specialization

Citations

This map shows the geographic impact of Kissy Guevara‐Hoyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kissy Guevara‐Hoyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kissy Guevara‐Hoyer more than expected).

Fields of papers citing papers by Kissy Guevara‐Hoyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kissy Guevara‐Hoyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kissy Guevara‐Hoyer. The network helps show where Kissy Guevara‐Hoyer may publish in the future.

Co-authorship network of co-authors of Kissy Guevara‐Hoyer

This figure shows the co-authorship network connecting the top 25 collaborators of Kissy Guevara‐Hoyer. A scholar is included among the top collaborators of Kissy Guevara‐Hoyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kissy Guevara‐Hoyer. Kissy Guevara‐Hoyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Descriptive analysis of immunological abnormalities in recurrent reproductive failure and therapeutical outcomes 2025 ·Medwave ·(unknown), (unknown), (unknown), (unknown), (unknown), Kissy Guevara‐Hoyer, (unknown), (unknown), Michael Ruiz, (unknown), (unknown), (unknown), (unknown), (unknown), Miguel Fernández‐Arquero, Ignacio Cristóbal García, Silvia Sánchez‐Ramón	1
2	Cancer Genomic Alterations and Microenvironmental Features Encode Synergistic Interactions with Disease Outcomes 2025 ·Molecular Cancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jyoti Mishra, (unknown), Kissy Guevara‐Hoyer, Chris McIntosh, Mamatha Bhat, Jüri Reimand	0
3	Association between human leukocyte antigen E expression and outcomes in solid tumors: a systematic review and meta-analysis 2025 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Kissy Guevara‐Hoyer, (unknown), (unknown), (unknown), Silvia Sánchez‐Ramón, Alberto Ocaña	1
4	Recurrent reproductive failure and celiac genetic susceptibility, a leading role of gluten 2024 ·Frontiers in Immunology ·(unknown), Miguel Fernández‐Arquero, (unknown), Kissy Guevara‐Hoyer, (unknown), (unknown), Marina P. Sánchez, (unknown), María G. Guzmán, (unknown), María José Mansilla, Noelia Pérez, Ricardo Savirón‐Cornudella, (unknown), (unknown), Ignacio Cristóbal García, Silvia Sánchez‐Ramón	2
5	Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer 2024 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), Kissy Guevara‐Hoyer, (unknown), Alejandra Sánchez, E. D. Carosella, Alberto Ocaña, Silvia Sánchez‐Ramón	4
6	An Exploratory Approach of Clinically Useful Biomarkers of Cvid by Logistic Regression 2024 ·Journal of Clinical Immunology ·(unknown), (unknown), Adolfo Jiménez‐Huete, Kissy Guevara‐Hoyer, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), María G. Guzmán, Miguel Fernández‐Arquero, Rebeca Pérez de Diego, Silvia Sánchez‐Ramón	1
7	Pan-cancer ion transport signature reveals functional regulators of glioblastoma aggression 2024 ·The EMBO Journal ·(unknown), Hyun-Kee Min, (unknown), Hongyu Zhao, (unknown), Weifan Dong, Irakli Dzneladze, (unknown), Xin Chen, Kissy Guevara‐Hoyer, Peter B. Dirks, Xi Huang, Jüri Reimand	7
8	Specific Cellular and Humoral Response after the Third Dose of Anti-SARS-CoV-2 RNA Vaccine in Patients with Immune-Mediated Rheumatic Diseases on Immunosuppressive Therapy 2023 ·Biomedicines ·(unknown), (unknown), (unknown), Kissy Guevara‐Hoyer, D. Freites, (unknown), (unknown), Benjamín Fernández‐Gutiérrez, (unknown), (unknown), (unknown), (unknown), (unknown), Esther Toledano, (unknown), (unknown), Pedro Pérez Segura, Silvia Sánchez‐Ramón, Gloria Candelas	0
9	Long-Term Benefit of Perlingual Polybacterial Vaccines in Patients with Systemic Autoimmune Diseases and Active Immunosuppression 2023 ·Biomedicines ·(unknown), (unknown), (unknown), Kissy Guevara‐Hoyer, (unknown), (unknown), D. Freites, Virginia Villaverde, Miguel Fernández‐Arquero, Benjamín Fernández‐Gutiérrez, Silvia Sánchez‐Ramón, Gloria Candelas	5
10	Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression 2022 ·Biomedicines ·(unknown), Kissy Guevara‐Hoyer, (unknown), Rebeca Pérez de Diego, (unknown), Marta Polo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Miguel Fernández‐Arquero, (unknown), (unknown), Silvia Sánchez‐Ramón	3
11	Genomic crossroads between non-Hodgkin’s lymphoma and common variable immunodeficiency 2022 ·Frontiers in Immunology ·Kissy Guevara‐Hoyer, Jesús Fuentes‐Antrás, (unknown), Miguel Fernández‐Arquero, Fernando Solano, Pedro Pérez‐Segura, Esmeralda Neves, Alberto Ocaña, Rebeca Pérez de Diego, Silvia Sánchez‐Ramón	9
12	Intravenous Immunoglobulins Promote an Expansion of Monocytic Myeloid-Derived Suppressor Cells (MDSC) in CVID Patients 2022 ·Journal of Clinical Immunology ·(unknown), Silvia Sánchez‐Ramón, (unknown), Bárbara Alonso, Kissy Guevara‐Hoyer, Miguel A. Vega, Ángel L. Corbí, Ángeles Domínguez‐Soto	4
13	Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients 2022 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), Kissy Guevara‐Hoyer, Miguel Fernández‐Arquero, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Silvia Sánchez‐Ramón, Pedro Pérez Segura	19
14	Case Report: Novel STIM1 Gain-of-Function Mutation in a Patient With TAM/STRMK and Immunological Involvement 2022 ·Frontiers in Immunology ·(unknown), (unknown), Blanca García‐Solis, (unknown), Kissy Guevara‐Hoyer, Miguel Fernández‐Arquero, Lucía Galán Dávila, Jorge Matías‐Guiu, Silvia Sánchez‐Ramón, Rebeca Pérez de Diego	2
15	Immunodeficiency and thymoma in Good syndrome: Two sides of the same coin 2021 ·Immunology Letters ·Kissy Guevara‐Hoyer, Jesús Fuentes‐Antrás, (unknown), Silvia Sánchez‐Ramón	15
16	Trained Immunity-Based Vaccine in B Cell Hematological Malignancies With Recurrent Infections: A New Therapeutic Approach 2021 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Laura Conejero, (unknown), (unknown), Carmen M. Diez‐Rivero, (unknown), Kissy Guevara‐Hoyer, Miguel Fernández‐Arquero, Silvia Sánchez‐Ramón	10
17	Fatal Autoimmune Storm After a Single Cycle of Anti-PD-1 Therapy 2020 ·Hematology/Oncology and Stem Cell Therapy ·Jesús Fuentes‐Antrás, (unknown), Kissy Guevara‐Hoyer, Cristina Díaz del Arco, Silvia Sánchez‐Ramón, Carlos Aguado	14
18	Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine 2020 ·Frontiers in Oncology ·Jesús Fuentes‐Antrás, Kissy Guevara‐Hoyer, Mariona Baliu‐Piqué, José Á. García-Sáenz, Pedro Pérez‐Segura, Atanasio Pandiella, Alberto Ocaña	39
19	Measurement of Typhim Vi IgG as a Diagnostic Tool to Determine Anti-polysaccharide Antibody Production Deficiency in Children 2019 ·Frontiers in Immunology ·Kissy Guevara‐Hoyer, (unknown), Antony R. Parker, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), María J. Recio, Miguel Fernández‐Arquero, Rebeca Pérez de Diego, José Tomás Ramos, Silvia Sánchez‐Ramón	8
20	Evaluation of Polysaccharide Typhim Vi Antibody Response as a predictor of Humoral Immunodeficiency in Haematological Malignancies 2019 ·Clinical Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kissy Guevara‐Hoyer, (unknown), (unknown), Miguel Fernández‐Arquero, (unknown), (unknown), María J. Recio, Rebeca Pérez de Diego, Remigio Martínez, Silvia Sánchez‐Ramón	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact